Načítá se...

NC‐6300, an epirubicin‐incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin

Epirubicin is widely used to treat various human tumors. However, it is difficult to achieve a sufficient antitumor effect because of dosage limitation to prevent cardiotoxicity. We hypothesized that epirubicin‐incorporating micelle would reduce cardiotoxicity and improve the antitumor effect. NC‐63...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Sci
Hlavní autoři: Takahashi, Amane, Yamamoto, Yoshiyuki, Yasunaga, Masahiro, Koga, Yoshikatsu, Kuroda, Jun‐ichiro, Takigahira, Misato, Harada, Mitsunori, Saito, Hiroyuki, Hayashi, Tatsuyuki, Kato, Yasuki, Kinoshita, Taira, Ohkohchi, Nobuhiro, Hyodo, Ichinosuke, Matsumura, Yasuhiro
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657135/
https://ncbi.nlm.nih.gov/pubmed/23495762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12153
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!